Published 14 hours ago • loading... • Updated 14 hours ago

The FDA's new psychedelic rules are groovy, but the agency is still a bad trip

Summary by Reason

The Trump administration is easing restrictions on psychedelic therapies, but the FDA’s slow approval system still stifles innovation.

The Trump administration is easing restrictions on psychedelic therapies, but the FDA’s slow approval system still stifles innovation.

14 hours ago·United States

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated12 hours agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Reason broke the news in United States 14 hours ago on Friday, May 15, 2026.

Sources are mostly out of (0)